You are here

AusPAR: Ceritinib

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

11 March 2020
AusPAR Details
AusPAR
Active Ingredient
Ceritinib
Product Name
Zykadia
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Submission Number
PM-2017-00696-1-4
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
4 March 2020
Publication Date

11 March 2020